These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 24885373)

  • 1. Role of platelet-derived growth factor/platelet-derived growth factor receptor axis in the trafficking of circulating fibrocytes in pulmonary fibrosis.
    Aono Y; Kishi M; Yokota Y; Azuma M; Kinoshita K; Takezaki A; Sato S; Kawano H; Kishi J; Goto H; Uehara H; Izumi K; Nishioka Y
    Am J Respir Cell Mol Biol; 2014 Dec; 51(6):793-801. PubMed ID: 24885373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blockade of platelet-derived growth factor receptor-β, not receptor-α ameliorates bleomycin-induced pulmonary fibrosis in mice.
    Kishi M; Aono Y; Sato S; Koyama K; Azuma M; Abe S; Kawano H; Kishi J; Toyoda Y; Okazaki H; Ogawa H; Uehara H; Nishioka Y
    PLoS One; 2018; 13(12):e0209786. PubMed ID: 30596712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet-derived growth factor expression and function in idiopathic pulmonary arterial hypertension.
    Perros F; Montani D; Dorfmüller P; Durand-Gasselin I; Tcherakian C; Le Pavec J; Mazmanian M; Fadel E; Mussot S; Mercier O; Hervé P; Emilie D; Eddahibi S; Simonneau G; Souza R; Humbert M
    Am J Respir Crit Care Med; 2008 Jul; 178(1):81-8. PubMed ID: 18420966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-fibrotic efficacy of nintedanib in pulmonary fibrosis via the inhibition of fibrocyte activity.
    Sato S; Shinohara S; Hayashi S; Morizumi S; Abe S; Okazaki H; Chen Y; Goto H; Aono Y; Ogawa H; Koyama K; Nishimura H; Kawano H; Toyoda Y; Uehara H; Nishioka Y
    Respir Res; 2017 Sep; 18(1):172. PubMed ID: 28915889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of platelet-derived growth factor signaling in healing myocardial infarcts.
    Zymek P; Bujak M; Chatila K; Cieslak A; Thakker G; Entman ML; Frangogiannis NG
    J Am Coll Cardiol; 2006 Dec; 48(11):2315-23. PubMed ID: 17161265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrocytes contribute to inflammation and fibrosis in chronic hypersensitivity pneumonitis through paracrine effects.
    García de Alba C; Buendia-Roldán I; Salgado A; Becerril C; Ramírez R; González Y; Checa M; Navarro C; Ruiz V; Pardo A; Selman M
    Am J Respir Crit Care Med; 2015 Feb; 191(4):427-36. PubMed ID: 25531246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemosensitization by STI571 targeting the platelet-derived growth factor/platelet-derived growth factor receptor-signaling pathway in the tumor progression and angiogenesis of gastric carcinoma.
    Kim R; Emi M; Arihiro K; Tanabe K; Uchida Y; Toge T
    Cancer; 2005 May; 103(9):1800-9. PubMed ID: 15786421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imatinib mesylate inhibits platelet-derived growth factor receptor phosphorylation of melanoma cells but does not affect tumorigenicity in vivo.
    McGary EC; Onn A; Mills L; Heimberger A; Eton O; Thomas GW; Shtivelband M; Bar-Eli M
    J Invest Dermatol; 2004 Feb; 122(2):400-5. PubMed ID: 15009722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pirfenidone inhibits fibrocyte accumulation in the lungs in bleomycin-induced murine pulmonary fibrosis.
    Inomata M; Kamio K; Azuma A; Matsuda K; Kokuho N; Miura Y; Hayashi H; Nei T; Fujita K; Saito Y; Gemma A
    Respir Res; 2014 Feb; 15(1):16. PubMed ID: 24507087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis.
    Phillips RJ; Burdick MD; Hong K; Lutz MA; Murray LA; Xue YY; Belperio JA; Keane MP; Strieter RM
    J Clin Invest; 2004 Aug; 114(3):438-46. PubMed ID: 15286810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet-derived growth factor and its receptors are related to the progression of human muscular dystrophy: an immunohistochemical study.
    Zhao Y; Haginoya K; Sun G; Dai H; Onuma A; Iinuma K
    J Pathol; 2003 Sep; 201(1):149-59. PubMed ID: 12950028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting Effectiveness of Imatinib Mesylate in Tumors Expressing Platelet-Derived Growth Factors (PDGF-AA, PDGF-BB), Stem Cell Factor Ligands and Their Respective Receptors (PDGFR-α, PDGFR-β, and c-kit).
    Moawad EY
    J Gastrointest Cancer; 2015 Sep; 46(3):272-83. PubMed ID: 25985771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antifibrotic effects of CXCR4 antagonist in bleomycin-induced pulmonary fibrosis in mice.
    Makino H; Aono Y; Azuma M; Kishi M; Yokota Y; Kinoshita K; Takezaki A; Kishi J; Kawano H; Ogawa H; Uehara H; Izumi K; Sone S; Nishioka Y
    J Med Invest; 2013; 60(1-2):127-37. PubMed ID: 23614921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glomerular expression of platelet-derived growth factor (PDGF)-A, -B chain and PDGF receptor-alpha, -beta in human diabetic nephropathy.
    Uehara G; Suzuki D; Toyoda M; Umezono T; Sakai H
    Clin Exp Nephrol; 2004 Mar; 8(1):36-42. PubMed ID: 15067514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrocyte CXCR4 regulation as a therapeutic target in pulmonary fibrosis.
    Mehrad B; Burdick MD; Strieter RM
    Int J Biochem Cell Biol; 2009; 41(8-9):1708-18. PubMed ID: 19433312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet-derived growth factor receptor beta inhibition increases tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) sensitivity: imatinib and TRAIL dual therapy.
    Wang Y; Mandal D; Wang S; Kleinerman ES; Pollock RE; Lev D; Hayes-Jordan A
    Cancer; 2010 Aug; 116(16):3892-902. PubMed ID: 20564078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of imatinib mesylate on bleomycin-induced pulmonary fibrosis in mice].
    Li L; Li YQ
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Apr; 19(4):229-32. PubMed ID: 17448279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imatinib mesylate inhibits cell invasion of malignant peripheral nerve sheath tumor induced by platelet-derived growth factor-BB.
    Aoki M; Nabeshima K; Koga K; Hamasaki M; Suzumiya J; Tamura K; Iwasaki H
    Lab Invest; 2007 Aug; 87(8):767-79. PubMed ID: 17558420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrocytes are a potential source of lung fibroblasts in idiopathic pulmonary fibrosis.
    Andersson-Sjöland A; de Alba CG; Nihlberg K; Becerril C; Ramírez R; Pardo A; Westergren-Thorsson G; Selman M
    Int J Biochem Cell Biol; 2008; 40(10):2129-40. PubMed ID: 18374622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential roles of growth factor PDGF-BB in the bony repair of injured growth plate.
    Chung R; Foster BK; Zannettino AC; Xian CJ
    Bone; 2009 May; 44(5):878-85. PubMed ID: 19442606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.